Open-Label, Extension Study to 810P202

Summary

Open-label, extension study for subjects that completed 810P202 to examine long term safety and tolerability of repeated dosing of SPN-810M as an adjunctive therapy in children with Impulsive Aggression Comorbid with Attention-Deficit/Hyperactivity Disorder (ADHD).

Timeline

Start

2011-09

Primary completion

2013-01

Completion

2013-02

Drugs

Indications